GB0904271D0 - Treatment of diabetes and metabolic syndrome - Google Patents

Treatment of diabetes and metabolic syndrome

Info

Publication number
GB0904271D0
GB0904271D0 GB0904271A GB0904271A GB0904271D0 GB 0904271 D0 GB0904271 D0 GB 0904271D0 GB 0904271 A GB0904271 A GB 0904271A GB 0904271 A GB0904271 A GB 0904271A GB 0904271 D0 GB0904271 D0 GB 0904271D0
Authority
GB
United Kingdom
Prior art keywords
diabetes
treatment
metabolic syndrome
metabolic
syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0904271A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordic Bioscience AS
Original Assignee
Nordic Bioscience AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordic Bioscience AS filed Critical Nordic Bioscience AS
Priority to GB0904271A priority Critical patent/GB0904271D0/en
Publication of GB0904271D0 publication Critical patent/GB0904271D0/en
Priority to BRPI1009392A priority patent/BRPI1009392A2/en
Priority to MX2011009559A priority patent/MX2011009559A/en
Priority to CN201080011177.1A priority patent/CN102369018B/en
Priority to AU2010223329A priority patent/AU2010223329B2/en
Priority to CA2755068A priority patent/CA2755068C/en
Priority to EP10708193.7A priority patent/EP2405934B1/en
Priority to JP2011553445A priority patent/JP5993147B2/en
Priority to EP14159411.9A priority patent/EP2762150A1/en
Priority to NZ595021A priority patent/NZ595021A/en
Priority to PCT/EP2010/053044 priority patent/WO2010103045A1/en
Priority to US13/255,854 priority patent/US20120046224A1/en
Priority to RU2011141291/15A priority patent/RU2537181C2/en
Priority to KR1020117023810A priority patent/KR101673042B1/en
Priority to CL2011002229A priority patent/CL2011002229A1/en
Ceased legal-status Critical Current

Links

GB0904271A 2009-03-12 2009-03-12 Treatment of diabetes and metabolic syndrome Ceased GB0904271D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GB0904271A GB0904271D0 (en) 2009-03-12 2009-03-12 Treatment of diabetes and metabolic syndrome
KR1020117023810A KR101673042B1 (en) 2009-03-12 2010-03-10 Treatment of diabetes and metabolic syndrome
EP10708193.7A EP2405934B1 (en) 2009-03-12 2010-03-10 Treatment of diabetes and metabolic syndrome
EP14159411.9A EP2762150A1 (en) 2009-03-12 2010-03-10 Treatment of Diabetes and Metabolic Syndrome
CN201080011177.1A CN102369018B (en) 2009-03-12 2010-03-10 Diabetes and the treatment of metabolism syndrome
AU2010223329A AU2010223329B2 (en) 2009-03-12 2010-03-10 Treatment of diabetes and metabolic syndrome
CA2755068A CA2755068C (en) 2009-03-12 2010-03-10 Treatment of diabetes and metabolic syndrome
BRPI1009392A BRPI1009392A2 (en) 2009-03-12 2010-03-10 "pharmaceutical formulation, and use of a pharmaceutically effective amount of a pharmaceutical formulation."
JP2011553445A JP5993147B2 (en) 2009-03-12 2010-03-10 Treatment of diabetes and metabolic syndrome
MX2011009559A MX2011009559A (en) 2009-03-12 2010-03-10 Treatment of diabetes and metabolic syndrome.
NZ595021A NZ595021A (en) 2009-03-12 2010-03-10 Treatment of diabetes and metabolic syndrome with enteral formulations of calcitonin peptides or calcitonin receptor agonists
PCT/EP2010/053044 WO2010103045A1 (en) 2009-03-12 2010-03-10 Treatment of diabetes and metabolic syndrome
US13/255,854 US20120046224A1 (en) 2009-03-12 2010-03-10 Treatment of diabetes and metabolic syndrome
RU2011141291/15A RU2537181C2 (en) 2009-03-12 2010-03-10 Treating diabetes and metabolic syndrome
CL2011002229A CL2011002229A1 (en) 2009-03-12 2011-09-09 Pharmaceutical formulation comprising an active compound that is a member of the calcitonin family that is not amylin.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0904271A GB0904271D0 (en) 2009-03-12 2009-03-12 Treatment of diabetes and metabolic syndrome

Publications (1)

Publication Number Publication Date
GB0904271D0 true GB0904271D0 (en) 2009-04-22

Family

ID=40600933

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0904271A Ceased GB0904271D0 (en) 2009-03-12 2009-03-12 Treatment of diabetes and metabolic syndrome

Country Status (1)

Country Link
GB (1) GB0904271D0 (en)

Similar Documents

Publication Publication Date Title
IL259475A (en) Combination therapy for the treatment of diabetes
IL210856A0 (en) Combination therapy for the treatment of diabetes and related conditions
PL3181134T3 (en) Bifidobacteria for treating diabetes and related conditions
GB2496799B (en) A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders
SI2376077T1 (en) Composition and method for treatment of diabetes
IL223289A0 (en) Treatment of type 2 diabetes
EP2434010A4 (en) Prophylactic and/or therapeutic agent for metabolic syndrome
EP2480246A4 (en) Composition and method for treatment of diabetes
HK1169993A1 (en) Hsl inhibitors useful in the treatment of diabetes hsl
PL2397151T3 (en) Treatment of vascular complications of diabetes
EP2498810A4 (en) Treatment of sleep disordered breathing with neurotoxin
HK1202819A1 (en) Treatment of type i and type ii diabetes i ii
EP2437771A4 (en) Compositions and methods modulating mg29 for the treatment of diabetes
EP2498794A4 (en) Method of treatment of type 2 diabetes
GB0912906D0 (en) Treatment of diabetes and metabolic syndrome
GB0910904D0 (en) Treatment of diabetes and metabolic syndrome
GB0904271D0 (en) Treatment of diabetes and metabolic syndrome
GB201003894D0 (en) Inhibitors of glucose metabolism for use in the treatment of Birt-Hogg-Dubé syndrome
EP2598152A4 (en) Treatment of metabolic syndrome and insulin resistance with citrus flavanones
EP2356986A4 (en) Composition for treatment of metabolic syndrome
GB0802904D0 (en) Treatment of metabolic syndrome
GB0802903D0 (en) Treatment of diabetes
AU2009900265A0 (en) Treatment of diabetes and other diseases
AU2010902914A0 (en) Treatment of diabetes
GB201007977D0 (en) Treatment of cardiovascular disease

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)